A Predictive Phosphorylation Signature of Lung Cancer

DSpace/Manakin Repository

A Predictive Phosphorylation Signature of Lung Cancer

Citable link to this page


Title: A Predictive Phosphorylation Signature of Lung Cancer
Author: Rikova, Klarisa; Merberg, David; Kasif, Simon; Steffen, Martin; Creighton, Chad; Wu, Chang-Jiun; Cai, Tianxi

Note: Order does not necessarily reflect citation order of authors.

Citation: Wu, Chang-Jiun, Tianxi Cai, Klarisa Rikova, David Merberg, Simon Kasif, and Martin Steffen. 2009. A Predictive Phosphorylation Signature of Lung Cancer. PLoS ONE 4(11): e7994.
Full Text & Related Files:
Abstract: Background: Aberrant activation of signaling pathways drives many of the fundamental biological processes that accompany tumor initiation and progression. Inappropriate phosphorylation of intermediates in these signaling pathways are a frequently observed molecular lesion that accompanies the undesirable activation or repression of pro- and anti-oncogenic pathways. Therefore, methods which directly query signaling pathway activation via phosphorylation assays in individual cancer biopsies are expected to provide important insights into the molecular “logic” that distinguishes cancer and normal tissue on one hand, and enables personalized intervention strategies on the other. Results: We first document the largest available set of tyrosine phosphorylation sites that are, individually, differentially phosphorylated in lung cancer, thus providing an immediate set of drug targets. Next, we develop a novel computational methodology to identify pathways whose phosphorylation activity is strongly correlated with the lung cancer phenotype. Finally, we demonstrate the feasibility of classifying lung cancers based on multi-variate phosphorylation signatures. Conclusions: Highly predictive and biologically transparent phosphorylation signatures of lung cancer provide evidence for the existence of a robust set of phosphorylation mechanisms (captured by the signatures) present in the majority of lung cancers, and that reliably distinguish each lung cancer from normal. This approach should improve our understanding of cancer and help guide its treatment, since the phosphorylation signatures highlight proteins and pathways whose phosphorylation should be inhibited in order to prevent unregulated proliferation.
Published Version: doi:10.1371/journal.pone.0007994
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777383/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4553773
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search